<!DOCTYPE HTML>
<!--
	Editorial by HTML5 UP
	html5up.net | @ajlkn
	Free for personal and commercial use under the CCA 3.0 license (html5up.net/license)
-->
<html>
	<head>
		<title>Generic - Editorial by HTML5 UP</title>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1, user-scalable=no" />
		<link rel="stylesheet" href="assets/css/main.css" />
	</head>
	<body class="is-preload">

		<!-- Wrapper -->
			<div id="wrapper">

				<!-- Main -->
					<div id="main">
						<div class="inner">

							<!-- Header -->
								<header id="header">
									<a href="index.html" class="logo"><strong>CELL Team Six</strong></a>
								</header>

							<!-- Content -->
								<section>
									<header class="main">
										<h1>Anaplastic lymphoma kinase (ALK)</h1>
									</header>


									Abnormalities in the ALK pathway result in cancer development, such as anaplastic large cell lymphoma, neuroblastoma, or non-small lung cancer. Carcinogenesis results from ALK gene fusion with oncogenes, gene mutation, amplification, and an increase in protein expression. Usually, these genetic changes lead to constitutively active ALK receptor tyrosine kinase, consequently activating downstream signaling pathways and leading to uncontrolled cell growth, anti-apoptotic signaling, and cellular transformation.

									Della Corte C.M., Viscardi G., Di Liello R., Fasano M., Martinelli E., Troiani T., Ciardiello F., Morgillo F. 2018. Role and targeting of anaplastic lymphoma kinase in cancer. Mol. Cancer, 17.





								</section>

						</div>
					</div>

				<!-- Sidebar -->
					<div id="sidebar">
						<div class="inner">



							<!-- Menu -->
								<nav id="menu">
									<header class="major">
										<h2>Menu</h2>
									</header>
									<ul>
										<li><a href="index.html">ALK pathway</a></li>
										<li><a href="ras.html">Ras family</a></li>
										<li>
											<span class="opener">Sequence information</span>
											<ul>
												<li><a href="fasta.html">FASTA</a></li>
												<li><a href="msa.html">Multiple Sequence Alignment</a></li>
												<li><a href="blast.html">BLAST</a></li>
											</ul>
										</li>
										<li>
											<span class="opener">Structure</span>
											<ul>
												<li><a href="#">Overview</a></li>
												<li><a href="#">Ipsum Adipiscing</a></li>
												<li><a href="#">Tempus Magna</a></li>
												<li><a href="#">Feugiat Veroeros</a></li>
											</ul>
										</li>
										<li><a href="#">Clinical implications</a></li>
										<li><a href="#">Summary</a></li>
									</ul>
								</nav>


							<!-- Section -->
								<section>
									<header class="major">
										<h2>Created by</h2>
									</header>
									<p>CELL Team Six</p>
									<ul class="contact">
										<li class="icon solid fa-envelope"><a href="#">information@untitled.tld</a></li>
									</ul>
								</section>

							<!-- Footer -->
								<footer id="footer">
									<p class="copyright">&copy; All rights reserved. Design: <a href="https://html5up.net">HTML5 UP</a>.</p>
								</footer>

						</div>
					</div>

			</div>

		<!-- Scripts -->
			<script src="assets/js/jquery.min.js"></script>
			<script src="assets/js/browser.min.js"></script>
			<script src="assets/js/breakpoints.min.js"></script>
			<script src="assets/js/util.js"></script>
			<script src="assets/js/main.js"></script>

	</body>
</html>
